Jamie Baumgartner

Jamie Baumgartner is the newly appointed President and Chief Executive Officer of Keystone Symposia on Molecular & Cellular Biology, a leading nonprofit organization specializing in biomedical and life sciences conferences.12 He assumed this role in July 2024, succeeding Dr. Debbie Johnson who retired after six years of leadership.2

Professional Background

Jamie Baumgartner brings over 20 years of experience in the biotechnology and pharmaceutical sectors.1 His career highlights include:

• Strategic Vision: He is renowned for his strategic vision and scientific expertise.1
• Drug Discovery: Jamie has guided hundreds of biotech and pharma companies to achieve significant milestones in drug discovery and development, leading to successful IND filings and market launches.1
• Natural Product Research: He has been instrumental in advancing natural product research and development.1
• Innovation: Jamie has driven innovation across diverse therapeutic areas.1

Previous Roles

Before joining Keystone Symposia, Jamie held several leadership positions:

• President and Chief Scientific Officer at Panacea Life Sciences
• CEO of Phoenix Life Sciences
• COO at Strategic Pharma Inc.13

Education

Jamie Baumgartner holds:

• A Bachelor of Science in Biochemistry from the University of California, Davis
• A Ph.D. in Biochemistry from Washington State University1

Leadership Philosophy

Jamie's leadership philosophy emphasizes collaboration, innovation, and inclusivity in scientific endeavors.1 He is passionate about Keystone Symposia's mission to bring scientists together to accelerate discoveries that benefit society.2

Vision for Keystone Symposia

As the new CEO, Jamie aims to:

1. Address the changing interests and needs of the scientific community
2. Provide value to trainees and early-career scientists
3. Create an inclusive and safe environment for diverse researchers
4. Uphold scientific excellence while fostering the next generation of researchers2

Jamie Baumgartner's appointment marks a new chapter for Keystone Symposia, with his extensive experience in both scientific innovation and business strategy positioning him to lead the organization into its next phase of growth and impact.1